PFAS exposure in early life: Health risks and maternal-fetal transport mechanisms

FHS
June 24, 2024
11:50 am

Polyfluoroalkyl substances (PFAS) are a class of chemicals extensively used in consumer goods production due to their hydrophobic and oleophobic properties and stability.

FDA OKs Second Gene Therapy for Hemophilia B

The FDA has approved a second gene therapy for adults with hemophilia B, drugmaker Pfizer announced on Friday. The approval of fidanacogene elaparvovec (Beqvez) stipulates

April 27, 2024

Owkin partners with AstraZeneca to enhance gBRCA testing for breast cancer

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, is pleased to announce a new partnership

October 4, 2024

Primate model unlocks clues to long-COVID’s impact on blood sugar, hints at vaccine benefits

The study uses a non-human primate model to explore the link between long-COVID and disruptions in glucose metabolism, finding a positive correlation. Vaccination appeared to

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.